BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28732103)

  • 1. Denosumab: Current Use in the Treatment of Primary Bone Tumors.
    Savvidou OD; Bolia IK; Chloros GD; Papanastasiou J; Koutsouradis P; Papagelopoulos PJ
    Orthopedics; 2017 Jul; 40(4):204-210. PubMed ID: 28732103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
    Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
    PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aneurysmal bone cyst and osteoblastoma after neoadjuvant denosumab: histologic spectrum and potential diagnostic pitfalls.
    Hung YP; Bredella MA; Lobmaier IVK; Lozano-Calderón SA; Rosenberg AE; Nielsen GP
    APMIS; 2022 Apr; 130(4):206-214. PubMed ID: 35114728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Denosumab: a new treatment option for giant cell tumor of bone.
    Lewin J; Thomas D
    Drugs Today (Barc); 2013 Nov; 49(11):693-700. PubMed ID: 24308016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denosumab Treatment for Giant Cell Tumors, Aneurysmal Bone Cysts, and Fibrous Dysplasia-Risks and Benefits.
    Pan KS; Boyce AM
    Curr Osteoporos Rep; 2021 Apr; 19(2):141-150. PubMed ID: 33616817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
    Branstetter DG; Nelson SD; Manivel JC; Blay JY; Chawla S; Thomas DM; Jun S; Jacobs I
    Clin Cancer Res; 2012 Aug; 18(16):4415-24. PubMed ID: 22711702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone.
    Lipplaa A; Dijkstra S; Gelderblom H
    Curr Opin Oncol; 2019 Jul; 31(4):329-335. PubMed ID: 30844887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denosumab for the treatment of giant cell tumor of the bone.
    Brodowicz T; Hemetsberger M; Windhager R
    Future Oncol; 2015; 11(13):1881-94. PubMed ID: 26161925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
    Roitman PD; Jauk F; Farfalli GL; Albergo JI; Aponte-Tinao LA
    Hum Pathol; 2017 May; 63():89-97. PubMed ID: 28235628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denosumab: Excellent response of metastatic giant cell tumor of the bone.
    Ulas A; Bulent Akinci M; Silay K; Sendur MA; Sener Dede D; Yalcin B
    J BUON; 2015; 20(2):666-7. PubMed ID: 26011370
    [No Abstract]   [Full Text] [Related]  

  • 12. Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report.
    Watanabe N; Matsumoto S; Shimoji T; Ae K; Tanizawa T; Gokita T; Motoi N; Ueno T; Koizumi M
    BMC Res Notes; 2014 Sep; 7():608. PubMed ID: 25193435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
    Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M
    Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of an aggressive periosteal aneurysmal bone cyst (ABC) of the radius to denosumab therapy.
    Pauli C; Fuchs B; Pfirrmann C; Bridge JA; Hofer S; Bode B
    World J Surg Oncol; 2014 Jan; 12():17. PubMed ID: 24438319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to Denosumab in 2 Children With Recurrent Giant Cell Tumor of the Bone With Pulmonary Metastasis.
    Reddy K; Ramirez L; Kukreja K; Venkatramani R
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e215-e218. PubMed ID: 31714440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic evaluation of the effect of denosumab on giant cell tumors of bone and a new grading scheme.
    Erdogan KE; DevecI MA; Paydas S; Gonlusen G
    Pol J Pathol; 2016; 67(4):392-397. PubMed ID: 28547968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant cell tumor of bone in childhood: clinical aspects and novel therapeutic targets.
    Federman N; Brien EW; Narasimhan V; Dry SM; Sodhi M; Chawla SP
    Paediatr Drugs; 2014 Feb; 16(1):21-8. PubMed ID: 24114694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts.
    Lange T; Stehling C; Fröhlich B; Klingenhöfer M; Kunkel P; Schneppenheim R; Escherich G; Gosheger G; Hardes J; Jürgens H; Schulte TL
    Eur Spine J; 2013 Jun; 22(6):1417-22. PubMed ID: 23455951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant Cell Tumor of Bone With Pseudosarcomatous Changes Leading to Premature Denosumab Therapy Interruption: A Case Report With Review of the Literature.
    Sanchez-Pareja A; Larousserie F; Boudabbous S; Beaulieu JY; Mach N; Saiji E; Rougemont AL
    Int J Surg Pathol; 2016 Jun; 24(4):366-72. PubMed ID: 26842345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
    Sørensen AL; Hansen RL; Jørgensen PH
    Ugeskr Laeger; 2016 Sep; 178(36):. PubMed ID: 27593237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.